A cost-effectiveness analysis of PHiD-CV compared to PCV13 in a national immunization program setting in Tunisia

Background In response to the substantial clinical and economic burden of diseases caused by Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) in Tunisia, the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) was recently introduce...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Youness Lagoubi, Mohamed Tahar Sfar, Jorge A. Gomez
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	Taylor & Francis Group 2022-11-01
سلاسل:	Human Vaccines & Immunotherapeutics
الموضوعات:	streptococcus pneumoniae pneumococcal conjugate vaccine 10-valent pneumococcal non-typeable haemophilus influenzae protein d conjugate vaccine 13-valent pneumococcal conjugate vaccine pcv10 pcv13 cost-effectiveness tunisia invasive pneumococcal disease acute otitis media phid-cv
الوصول للمادة أونلاين:	http://dx.doi.org/10.1080/21645515.2022.2079305
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!